Finance entity
Coverage clusters in markets, which accounts for 2 of those 3, with the remainder spread across 1 other category. Their average consequence score of 5.3 runs below the beat's 6.4 for that window. Veeva Systems is most often covered alongside Canaccord Genuity Group, which appears in 1 of these 3 stories.
Last mentioned: Aug 4, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 33 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Coverage clusters in markets, which accounts for 2 of those 3, with the remainder spread across 1 other category. Their average consequence score of 5.3 runs below the beat's 6.4 for that window. Veeva Systems is most often covered alongside Canaccord Genuity Group, which appears in 1 of these 3 stories. They are less corroborated than the beat average, carrying 2 original sources each against 2.6 for the same window. That works out to roughly 1.8 stories per week across a 12-day span. We currently track 3 Finance stories that mention Veeva Systems, published between March 4, 2026 and March 15, 2026.
Computed from the 3 stories linked to this entity, with beat comparisons drawn from all 1055 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Veeva Systems. Shared-story counts are live from our verified record — not editorial picks.
Analyst Target Cuts
TD Cowen and Canaccord Genuity slash price targets citing competitive risks and valuation.
Market Volatility
VEEV stock surges 11% on long-term outlook before retreating on disclosure concerns.
Q4 Earnings Report
Veeva reports advancing income and sets a $6B revenue target for 2030.
Competitive Disclosure
Management reveals competitive losses in the CRM segment during the earnings call.
Veeva Systems remains a dominant force in the life sciences cloud sector, boasting a 13.6% CAGR since its 2013 IPO and a client list including 15 of the top 20 biopharma firms. While revenue growth is moderating as the company matures, its $20 billion total addressable market and high switching costs suggest significant long-term compounding potential.
Veeva Systems (VEEV) is navigating a complex post-earnings landscape as major analysts, including TD Cowen and Canaccord Genuity, significantly lower their price targets. Despite a bullish long-term revenue outlook, recent management disclosures regarding competitive losses have triggered a wave of valuation adjustments across Wall Street.
As equity markets navigate 2026 volatility, analysts are highlighting a mix of established healthcare leaders and emerging AI infrastructure plays as top growth opportunities. Eli Lilly’s dominance in the obesity market and Nebius’s projected $7 billion revenue surge represent the diverse strategies for capturing alpha in the current cycle.
Veeva Systems is linked from 3 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
